Answers are grounded in this paper and cite their sources.
Case report reveals undetected residual neuromuscular blockade during quantitative monitoring in hemiparesis, highlighting monitoring pitfalls in paralyzed limbs.
The use of non-depolarising neuromuscular blocking agents (n-NMBAs) necessitates intraoperative neuromuscular function monitoring, as undetected residual neuromuscular blockade increases the risk of postoperative complications. The use of intraoperative quantitative neuromuscular monitoring (QNMM), including calibration before administration of neuromuscular blocking agent, is therefore recommended by UK,1 USA2 and European guidelines.3
No takes yet. Share an insight, caveat, or question.
Venema et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: